RAPP

Rapport Therapeutics Inc

• TipRanks·09/02 13:40

  Analysts Conflicted on These NA Names: Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP)

• TipRanks·08/28 10:20

  Analysts Offer Insights on NA Companies: Infleqtion (INFQ) and Rapport Therapeutics, Inc. (RAPP)

• NASDAQ·08/27 15:46

  Rapport Therapeutics Hits New 52-Week High As RAP-219 Advances Into Phase 3

• NASDAQ·08/27 09:22

  Biotech Stocks At 52-Week Highs - CRDL, NEO, SPTX, RAPP, CGEM

• Seeking Alpha·08/21 20:14

  Rapport Therapeutics: A 22-Day Half-Life Creates A Differentiated Epilepsy Franchise

• TipRanks·08/20 10:20

  Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)

• TipRanks·08/20 08:30

  Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)

• Dow Jones·08/19 10:33

  Rapport Therapeutics Price Target Maintained With a $65.00/Share by BTIG

• Benzinga·08/19 10:25

  BTIG Reiterates Buy on Rapport Therapeutics, Maintains $65 Price Target

• TipRanks·08/17 13:20

  Rapport Therapeutics price target raised to $75 from $68 at Raymond James

• TipRanks·08/17 12:28

  H.C. Wainwright Sticks to Its Buy Rating for Rapport Therapeutics, Inc. (RAPP)

• TipRanks·08/17 09:07

  Rapport Therapeutics price target raised to $66 from $40 at H.C. Wainwright

• TipRanks·08/13 15:35

  Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus

• Dow Jones·08/12 17:08

  Rapport Therapeutics Price Target Raised to $66.00/Share From $40.00 by HC Wainwright & Co.

• Benzinga·08/12 16:58

  HC Wainwright & Co. Maintains Buy on Rapport Therapeutics, Raises Price Target to $66